Pheton Holdings Ltd Class A Ordinary Shares (PTHL) 10-Year Financial Performance & Capital Metrics

PTHL • • Industrial / General

HealthcareMedical DevicesOncology & Cancer Treatment DevicesRadiation Therapy Systems

AboutPheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.Show more

Revenue $448K -28.7%
EBITDA -$698K -186.4%
Net Income -$661K -174.0%
EPS (Diluted) -0.05 -212.7%
Gross Margin 85.04% +13.5%
EBITDA Margin -155.64% -301.7%
Operating Margin -171.8% -252.1%
Net Margin -147.48% -284.3%
ROE -20.37% +63.6%
ROIC -223.38% -359.6%
Debt/Equity 0.04 -92.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Share count reduced 12.3% through buybacks

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 3 (bottom 3%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-13.92%

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-

EPS CAGR

10Y-

5Y-

3Y-

TTM-

ROCE

10Y Avg-15.77%

5Y Avg-15.77%

3Y Avg-24.88%

Latest-23.35%

Peer Comparison

Radiation Therapy Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
SRTSSensus Healthcare, Inc.	81.47M	4.96	12.10	71.31%	-8.44%	-5.87%	0.01
CATXPerspective Therapeutics, Inc.	184.36M	2.48	-2.02	-100%	-197.29%	-42.77%	0.01
TLSITriSalus Life Sciences, Inc.	307.28M	6.15	-4.92	58.99%	-98.45%
PROFProfound Medical Corp.	302.68M	8.34	-7.79	41.23%	-272.77%	-130.59%	0.08
DCTHDelcath Systems, Inc.	354.29M	10.21	-11.03	17.02%	1.5%	1.04%	0.02
PTHLPheton Holdings Ltd Class A Ordinary Shares	8.46M	0.90	-17.38	-28.7%	-91.16%	-13.91%	0.04
ARAYAccuray Incorporated	98.61M	0.87	-56.13	2.68%	-4.28%	-31.22%	2.17

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	702.78K	679.78K	628.59K	448.2K
Revenue Growth %	-	-0.03%	-0.08%	-0.29%
Cost of Goods Sold+	112.03K	121.63K	157.76K	67.04K
COGS % of Revenue	0.16%	0.18%	0.25%	0.15%
Gross Profit+	590.74K	558.15K	470.83K	381.15K
Gross Margin %	0.84%	0.82%	0.75%	0.85%
Gross Profit Growth %	-	-0.06%	-0.16%	-0.19%
Operating Expenses+	452.66K	530.63K	777.51K	1.15M
OpEx % of Revenue	0.64%	0.78%	1.24%	2.57%
Selling, General & Admin	371.44K	456.91K	693.03K	1.06M
SG&A % of Revenue	0.53%	0.67%	1.1%	2.36%
Research & Development	81.22K	73.72K	84.47K	93.32K
R&D % of Revenue	0.12%	0.11%	0.13%	0.21%
Other Operating Expenses	0	0	0	-324
Operating Income+	138.09K	27.52K	-306.68K	-770K
Operating Margin %	0.2%	0.04%	-0.49%	-1.72%
Operating Income Growth %	-	-0.8%	-12.14%	-1.51%
EBITDA+	204.04K	81.61K	-243.55K	-697.57K
EBITDA Margin %	0.29%	0.12%	-0.39%	-1.56%
EBITDA Growth %	-	-0.6%	-3.98%	-1.86%
D&A (Non-Cash Add-back)	65.95K	54.08K	63.13K	72.43K
EBIT	207.54K	74.53K	-258.51K	-662K
Net Interest Income+	0	0	0	0
Interest Income	0	0	0	0
Interest Expense	0	0	0	0
Other Income/Expense	65.44K	43.51K	46.17K	130.83K
Pretax Income+	203.53K	71.03K	-260.51K	-639.17K
Pretax Margin %	0.29%	0.1%	-0.41%	-1.43%
Income Tax+	11.07K	-12.95K	-19.29K	21.83K
Effective Tax Rate %	0.95%	1.18%	0.93%	1.03%
Net Income+	192.46K	83.98K	-241.22K	-661K
Net Margin %	0.27%	0.12%	-0.38%	-1.47%
Net Income Growth %	-	-0.56%	-3.87%	-1.74%
Net Income (Continuing)	192.46K	83.98K	-241.22K	-661K
Discontinued Operations	0	0	0	0
Minority Interest	0	0	0	0
EPS (Diluted)+	0.01	0.01	-0.02	-0.05
EPS Growth %	-	-0.56%	-	-2.13%
EPS (Basic)	0.01	0.01	-0.02	-0.05
Diluted Shares Outstanding	14.5M	14.5M	14.5M	12.72M
Basic Shares Outstanding	14.5M	14.5M	14.5M	12.72M
Dividend Payout Ratio	-	4.74%	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.02M	718.8K	532.47K	6.68M
Cash & Short-Term Investments	136.75K	72.29K	217.88K	6.16M
Cash Only	136.75K	72.29K	217.88K	6.16M
Short-Term Investments	0	0	0	0
Accounts Receivable	766.83K	475.09K	234.46K	308.06K
Days Sales Outstanding	398.27	255.09	136.14	250.88
Inventory	99.43K	152.79K	52.26K	117.42K
Days Inventory Outstanding	323.95	458.51	120.92	639.3
Other Current Assets	5.34K	3.6K	16.14K	92.35K
Total Non-Current Assets+	314.96K	682.93K	1.08M	45.59K
Property, Plant & Equipment	295.72K	217.93K	215.01K	45.59K
Fixed Asset Turnover	2.38x	3.12x	2.92x	9.83x
Goodwill	0	0	0	0
Intangible Assets	0	0	0	0
Long-Term Investments	0	0	0	0
Other Non-Current Assets	18.24K	462.06K	847.03K	0
Total Assets+	1.33M	1.4M	1.62M	6.72M
Asset Turnover	0.53x	0.48x	0.39x	0.07x
Asset Growth %	-	0.05%	0.15%	3.16%
Total Current Liabilities+	135.77K	680.4K	1.21M	538.55K
Accounts Payable	24.43K	11.17K	18K	10.41K
Days Payables Outstanding	79.59	33.52	41.64	56.69
Short-Term Debt	0	0	50.83K	247.97K
Deferred Revenue (Current)	12.55K	151.32K	58.25K	145.9K
Other Current Liabilities	838	0	-88.64K	0
Current Ratio	7.48x	1.06x	0.44x	12.40x
Quick Ratio	6.75x	0.83x	0.40x	12.18x
Cash Conversion Cycle	642.64	680.08	215.41	833.49
Total Non-Current Liabilities+	240.88K	165.01K	104.99K	0
Long-Term Debt	0	0	0	0
Capital Lease Obligations	240.88K	165.01K	104.99K	0
Deferred Tax Liabilities	0	0	0	0
Other Non-Current Liabilities	0	0	0	0
Total Liabilities	376.65K	845.41K	1.31M	538.55K
Total Debt+	297.4K	218.33K	155.82K	247.97K
Net Debt	160.65K	146.04K	-62.07K	-5.91M
Debt / Equity	0.31x	0.39x	0.51x	0.04x
Debt / EBITDA	1.46x	2.68x	-	-
Net Debt / EBITDA	0.79x	1.79x	-	-
Interest Coverage	-	-	-	-
Total Equity+	954.34K	556.32K	306.27K	6.18M
Equity Growth %	-	-0.42%	-0.45%	19.19%
Book Value per Share	0.07	0.04	0.02	0.49
Total Shareholders' Equity	954.34K	556.32K	306.27K	6.18M
Common Stock	1.2K	1.2K	1.2K	1.43K
Retained Earnings	701.82K	378.95K	137.74K	-522.85K
Treasury Stock	0	0	0	0
Accumulated OCI	131.74K	56.58K	46.62K	41.51K
Minority Interest	0	0	0	0

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	80.77K	-116.15K	-63.64K	-775K
Operating CF Margin %	0.11%	-0.17%	-0.1%	-1.73%
Operating CF Growth %	-	-2.44%	0.45%	-11.18%
Net Income	192.46K	83.98K	-241.22K	-660.59K
Depreciation & Amortization	65.95K	54.08K	63.13K	72.43K
Stock-Based Compensation	0	0	0	0
Deferred Taxes	-255	-2.09K	-19.29K	21.83K
Other Non-Cash Items	8.86K	15.52K	21.52K	21.84K
Working Capital Changes	-186.25K	-267.65K	112.22K	-230.51K
Change in Receivables	106.09K	-281.41K	212.31K	-119.98K
Change in Inventory	14.3K	-63.94K	33.5K	-67.55K
Change in Payables	-10.21K	-11.59K	7.06K	-7.2K
Cash from Investing+	0	0	0	-861
Capital Expenditures	0	0	0	-861
CapEx % of Revenue	0%	-	0%	0%
Acquisitions	-	-	-	-
Investments	-	-	-	-
Other Investing	0	0	0	0
Cash from Financing+	-72.82K	78.14K	220.59K	6.71M
Debt Issued (Net)	-	-	-	-
Equity Issued (Net)	-	-	-	-
Dividends Paid	0	-398.44K	0	0
Share Repurchases	-	-	-	-
Other Financing	-119.3K	476.58K	219.46K	-1.33M
Net Change in Cash	-	-	-	-
Free Cash Flow+	80.77K	-116.15K	-63.64K	-775.86K
FCF Margin %	0.11%	-0.17%	-0.1%	-1.73%
FCF Growth %	-	-2.44%	0.45%	-11.19%
FCF per Share	0.01	-0.01	-0.00	-0.06
FCF Conversion (FCF/Net Income)	0.42x	-1.38x	0.26x	1.17x
Interest Paid	0	0	0	0
Taxes Paid	38.99K	0	0	0

Key Ratios

Metric	2021	2022	2023	2024
Return on Equity (ROE)	20.17%	11.12%	-55.93%	-20.37%
Return on Invested Capital (ROIC)	9.29%	2.27%	-48.6%	-223.38%
Gross Margin	84.06%	82.11%	74.9%	85.04%
Net Margin	27.39%	12.35%	-38.37%	-147.48%
Debt / Equity	0.31x	0.39x	0.51x	0.04x
FCF Conversion	0.42x	-1.38x	0.26x	1.17x
Revenue Growth	-	-3.27%	-7.53%	-28.7%

Frequently Asked Questions

Growth & Financials

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) reported $0.9M in revenue for fiscal year 2024. This represents a 34% increase from $0.7M in 2021.

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) saw revenue decline by 28.7% over the past year.

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) reported a net loss of $0.9M for fiscal year 2024.

Dividend & Returns

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) has a return on equity (ROE) of -20.4%. Negative ROE indicates the company is unprofitable.

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) had negative free cash flow of $0.8M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener